Substance Withdrawal Syndrome
"Substance Withdrawal Syndrome" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Physiological and psychological symptoms associated with withdrawal from the use of a drug after prolonged administration or habituation. The concept includes withdrawal from smoking or drinking, as well as withdrawal from an administered drug.
| Descriptor ID |
D013375
|
| MeSH Number(s) |
C25.775.835 F03.900.825
|
| Concept/Terms |
Substance Withdrawal Syndrome- Substance Withdrawal Syndrome
- Substance Withdrawal Syndromes
- Syndrome, Substance Withdrawal
- Syndromes, Substance Withdrawal
- Withdrawal Syndrome, Substance
- Withdrawal Syndromes, Substance
Withdrawal Symptoms- Withdrawal Symptoms
- Symptom, Withdrawal
- Symptoms, Withdrawal
- Withdrawal Symptom
Drug Withdrawal Symptoms- Drug Withdrawal Symptoms
- Drug Withdrawal Symptom
- Symptom, Drug Withdrawal
- Symptoms, Drug Withdrawal
- Withdrawal Symptom, Drug
- Withdrawal Symptoms, Drug
|
Below are MeSH descriptors whose meaning is more general than "Substance Withdrawal Syndrome".
Below are MeSH descriptors whose meaning is more specific than "Substance Withdrawal Syndrome".
This graph shows the total number of publications written about "Substance Withdrawal Syndrome" by people in this website by year, and whether "Substance Withdrawal Syndrome" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 1 | 0 | 1 |
| 2000 | 1 | 0 | 1 |
| 2002 | 1 | 1 | 2 |
| 2003 | 1 | 1 | 2 |
| 2004 | 1 | 0 | 1 |
| 2005 | 0 | 2 | 2 |
| 2006 | 3 | 1 | 4 |
| 2008 | 3 | 1 | 4 |
| 2009 | 0 | 1 | 1 |
| 2010 | 1 | 1 | 2 |
| 2012 | 1 | 2 | 3 |
| 2014 | 3 | 0 | 3 |
| 2016 | 1 | 1 | 2 |
| 2017 | 0 | 1 | 1 |
| 2018 | 1 | 1 | 2 |
| 2021 | 1 | 0 | 1 |
| 2022 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Substance Withdrawal Syndrome" by people in Profiles.
-
Quintanilla ME, Quezada M, Morales P, Berr?os-C?rcamo P, Santapau D, Ezquer M, Herrera-Marschitz M, Israel Y, Ezquer F. Effect of human mesenchymal stem cell secretome administration on morphine self-administration and relapse in two animal models of opioid dependence. Transl Psychiatry. 2022 11 04; 12(1):462.
-
Schmitz NS, Krach LE, Coles LD, Schrogie J, Cloyd JC, Kriel RL. Characterizing Baclofen Withdrawal: A National Survey of Physician Experience. Pediatr Neurol. 2021 09; 122:106-109.
-
Ezquer F, Quintanilla ME, Morales P, Santapau D, Ezquer M, Kogan MJ, Salas-Huenuleo E, Herrera-Marschitz M, Israel Y. Intranasal delivery of mesenchymal stem cell-derived exosomes reduces oxidative stress and markedly inhibits ethanol consumption and post-deprivation relapse drinking. Addict Biol. 2019 09; 24(5):994-1007.
-
Myers AM, Siegele PB, Foss JD, Tuma RF, Ward SJ. Single and combined effects of plant-derived and synthetic cannabinoids on cognition and cannabinoid-associated withdrawal signs in mice. Br J Pharmacol. 2019 05; 176(10):1552-1567.
-
Sutter MB, Gopman S, Leeman L. Patient-centered Care to Address Barriers for Pregnant Women with Opioid Dependence. Obstet Gynecol Clin North Am. 2017 Mar; 44(1):95-107.
-
De Ridder D, Manning P, Leong SL, Ross S, Vanneste S. Allostasis in health and food addiction. Sci Rep. 2016 11 23; 6:37126.
-
Patel AN, Lee S, Andrews HF, Pelton GH, Schultz SK, Sultzer DL, Mintzer J, de la Pena D, Gupta S, Colon S, Schimming C, Levin B, Devanand DP. Prediction of Relapse After Discontinuation of Antipsychotic Treatment in Alzheimer's Disease: The Role of Hallucinations. Am J Psychiatry. 2017 04 01; 174(4):362-369.
-
Lee D, Schroeder JR, Karschner EL, Goodwin RS, Hirvonen J, Gorelick DA, Huestis MA. Cannabis withdrawal in chronic, frequent cannabis smokers during sustained abstinence within a closed residential environment. Am J Addict. 2014 May-Jun; 23(3):234-42.
-
Milman G, Bergamaschi MM, Lee D, Mendu DR, Barnes AJ, Vandrey R, Huestis MA. Plasma cannabinoid concentrations during dronabinol pharmacotherapy for cannabis dependence. Ther Drug Monit. 2014 Apr; 36(2):218-24.
-
Pecoraro A, Ewen E, Horton T, Mooney R, Kolm P, McGraw P, Woody G. Using the AUDIT-PC to predict alcohol withdrawal in hospitalized patients. J Gen Intern Med. 2014 Jan; 29(1):34-40.